By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Drugs > Cortisone acetate (monograph) > Cortisone Dosage
Drugs
https://themeditary.com/dosage-information/cortisone-dosage-12220.html

Cortisone Dosage

Drug Detail:Cortisone acetate (monograph) (Medically reviewed)

Drug Class:

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Adrenal Insufficiency

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Use(s): Primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis, hypercalcemia associated with cancer

Usual Adult Dose for Idiopathic (Immune) Thrombocytopenic Purpura

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired/autoimmune hemolytic anemia, erythroblastopenia (red blood cell anemia), congenital (erythroid) hypoplastic anemia

Usual Adult Dose for Shock

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired/autoimmune hemolytic anemia, erythroblastopenia (red blood cell anemia), congenital (erythroid) hypoplastic anemia

Usual Adult Dose for Hemolytic Anemia

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired/autoimmune hemolytic anemia, erythroblastopenia (red blood cell anemia), congenital (erythroid) hypoplastic anemia

Usual Adult Dose for Erythroblastopenia

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired/autoimmune hemolytic anemia, erythroblastopenia (red blood cell anemia), congenital (erythroid) hypoplastic anemia

Usual Adult Dose for Loeffler's Syndrome

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, fulminating or disseminated pulmonary tuberculosis (when used concomitantly with appropriate antituberculosis chemotherapy), aspiration pneumonitis

Usual Adult Dose for Sarcoidosis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, fulminating or disseminated pulmonary tuberculosis (when used concomitantly with appropriate antituberculosis chemotherapy), aspiration pneumonitis

Usual Adult Dose for Berylliosis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, fulminating or disseminated pulmonary tuberculosis (when used concomitantly with appropriate antituberculosis chemotherapy), aspiration pneumonitis

Usual Adult Dose for Lymphoma

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Palliative management of leukemia and lymphoma in adults

Usual Adult Dose for Nephrotic Syndrome

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: To induce diuresis or remission of proteinuria in nephrotic syndrome without uremia, idiopathic or from lupus erythematosus

Usual Adult Dose for Uveitis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as:
  • Allergic conjunctivitis
  • Keratitis
  • Allergic corneal marginal ulcers
  • Herpes zoster ophthalmicus
  • Iritis and iridocyclitis
  • Chorioretinitis
  • Anterior segment inflammation
  • Diffuse posterior uveitis and choroiditis
  • Optic neuritis
  • Sympathetic ophthalmia

Usual Adult Dose for Iritis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as:
  • Allergic conjunctivitis
  • Keratitis
  • Allergic corneal marginal ulcers
  • Herpes zoster ophthalmicus
  • Iritis and iridocyclitis
  • Chorioretinitis
  • Anterior segment inflammation
  • Diffuse posterior uveitis and choroiditis
  • Optic neuritis
  • Sympathetic ophthalmia

Usual Adult Dose for Keratitis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as:
  • Allergic conjunctivitis
  • Keratitis
  • Allergic corneal marginal ulcers
  • Herpes zoster ophthalmicus
  • Iritis and iridocyclitis
  • Chorioretinitis
  • Anterior segment inflammation
  • Diffuse posterior uveitis and choroiditis
  • Optic neuritis
  • Sympathetic ophthalmia

Usual Adult Dose for Conjunctivitis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as:
  • Allergic conjunctivitis
  • Keratitis
  • Allergic corneal marginal ulcers
  • Herpes zoster ophthalmicus
  • Iritis and iridocyclitis
  • Chorioretinitis
  • Anterior segment inflammation
  • Diffuse posterior uveitis and choroiditis
  • Optic neuritis
  • Sympathetic ophthalmia

Usual Adult Dose for Iridocyclitis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as:
  • Allergic conjunctivitis
  • Keratitis
  • Allergic corneal marginal ulcers
  • Herpes zoster ophthalmicus
  • Iritis and iridocyclitis
  • Chorioretinitis
  • Anterior segment inflammation
  • Diffuse posterior uveitis and choroiditis
  • Optic neuritis
  • Sympathetic ophthalmia

Usual Adult Dose for Chorioretinitis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as:
  • Allergic conjunctivitis
  • Keratitis
  • Allergic corneal marginal ulcers
  • Herpes zoster ophthalmicus
  • Iritis and iridocyclitis
  • Chorioretinitis
  • Anterior segment inflammation
  • Diffuse posterior uveitis and choroiditis
  • Optic neuritis
  • Sympathetic ophthalmia

Usual Adult Dose for Choroiditis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as:
  • Allergic conjunctivitis
  • Keratitis
  • Allergic corneal marginal ulcers
  • Herpes zoster ophthalmicus
  • Iritis and iridocyclitis
  • Chorioretinitis
  • Anterior segment inflammation
  • Diffuse posterior uveitis and choroiditis
  • Optic neuritis
  • Sympathetic ophthalmia

Usual Adult Dose for Systemic Lupus Erythematosus

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: For exacerbations or as maintenance therapy in select cases of systemic lupus erythematosus, acute rheumatic carditis, and systemic dermatomyositis (polymyositis)

Usual Adult Dose for Dermatomyositis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: For exacerbations or as maintenance therapy in select cases of systemic lupus erythematosus, acute rheumatic carditis, and systemic dermatomyositis (polymyositis)

Usual Adult Dose for Ankylosing Spondylitis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: As adjunctive therapy for short term administration (for acute episodes/exacerbations) in:
  • Psoriatic arthritis
  • Rheumatoid arthritis, including juvenile rheumatoid arthritis
  • Ankylosing spondylosis
  • Acute and subacute bursitis
  • Acute nonspecific tenosynovitis
  • Acute gouty arthritis
  • Post-traumatic osteoarthritis
  • Synovitis of osteoarthritis
  • Epicondylitis

Usual Adult Dose for Bursitis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: As adjunctive therapy for short term administration (for acute episodes/exacerbations) in:
  • Psoriatic arthritis
  • Rheumatoid arthritis, including juvenile rheumatoid arthritis
  • Ankylosing spondylosis
  • Acute and subacute bursitis
  • Acute nonspecific tenosynovitis
  • Acute gouty arthritis
  • Post-traumatic osteoarthritis
  • Synovitis of osteoarthritis
  • Epicondylitis

Usual Adult Dose for Osteoarthritis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: As adjunctive therapy for short term administration (for acute episodes/exacerbations) in:
  • Psoriatic arthritis
  • Rheumatoid arthritis, including juvenile rheumatoid arthritis
  • Ankylosing spondylosis
  • Acute and subacute bursitis
  • Acute nonspecific tenosynovitis
  • Acute gouty arthritis
  • Post-traumatic osteoarthritis
  • Synovitis of osteoarthritis
  • Epicondylitis

Usual Adult Dose for Rheumatoid Arthritis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: As adjunctive therapy for short term administration (for acute episodes/exacerbations) in:
  • Psoriatic arthritis
  • Rheumatoid arthritis, including juvenile rheumatoid arthritis
  • Ankylosing spondylosis
  • Acute and subacute bursitis
  • Acute nonspecific tenosynovitis
  • Acute gouty arthritis
  • Post-traumatic osteoarthritis
  • Synovitis of osteoarthritis
  • Epicondylitis

Usual Adult Dose for Gouty Arthritis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: As adjunctive therapy for short term administration (for acute episodes/exacerbations) in:
  • Psoriatic arthritis
  • Rheumatoid arthritis, including juvenile rheumatoid arthritis
  • Ankylosing spondylosis
  • Acute and subacute bursitis
  • Acute nonspecific tenosynovitis
  • Acute gouty arthritis
  • Post-traumatic osteoarthritis
  • Synovitis of osteoarthritis
  • Epicondylitis

Usual Adult Dose for Psoriatic Arthritis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: As adjunctive therapy for short term administration (for acute episodes/exacerbations) in:
  • Psoriatic arthritis
  • Rheumatoid arthritis, including juvenile rheumatoid arthritis
  • Ankylosing spondylosis
  • Acute and subacute bursitis
  • Acute nonspecific tenosynovitis
  • Acute gouty arthritis
  • Post-traumatic osteoarthritis
  • Synovitis of osteoarthritis
  • Epicondylitis

Usual Adult Dose for Epicondylitis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: As adjunctive therapy for short term administration (for acute episodes/exacerbations) in:
  • Psoriatic arthritis
  • Rheumatoid arthritis, including juvenile rheumatoid arthritis
  • Ankylosing spondylosis
  • Acute and subacute bursitis
  • Acute nonspecific tenosynovitis
  • Acute gouty arthritis
  • Post-traumatic osteoarthritis
  • Synovitis of osteoarthritis
  • Epicondylitis

Usual Adult Dose for Dermatitis Herpetiformis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses:
  • Pemphigus
  • Bullous dermatitis herpetiformis
  • Severe erythema multiforme (Stevens-Johnson syndrome)
  • Exfoliative dermatitis
  • Mycosis fungoides
  • Severe psoriasis
  • Severe seborrheic dermatitis

Usual Adult Dose for Psoriasis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses:
  • Pemphigus
  • Bullous dermatitis herpetiformis
  • Severe erythema multiforme (Stevens-Johnson syndrome)
  • Exfoliative dermatitis
  • Mycosis fungoides
  • Severe psoriasis
  • Severe seborrheic dermatitis

Usual Adult Dose for Seborrheic Dermatitis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses:
  • Pemphigus
  • Bullous dermatitis herpetiformis
  • Severe erythema multiforme (Stevens-Johnson syndrome)
  • Exfoliative dermatitis
  • Mycosis fungoides
  • Severe psoriasis
  • Severe seborrheic dermatitis

Usual Adult Dose for Pemphigus

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses:
  • Pemphigus
  • Bullous dermatitis herpetiformis
  • Severe erythema multiforme (Stevens-Johnson syndrome)
  • Exfoliative dermatitis
  • Mycosis fungoides
  • Severe psoriasis
  • Severe seborrheic dermatitis

Usual Adult Dose for Erythema Multiforme

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses:
  • Pemphigus
  • Bullous dermatitis herpetiformis
  • Severe erythema multiforme (Stevens-Johnson syndrome)
  • Exfoliative dermatitis
  • Mycosis fungoides
  • Severe psoriasis
  • Severe seborrheic dermatitis

Usual Adult Dose for Allergic Rhinitis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Control of severe or incapacitating allergic conditions retractable to adequate trials of conventional treatment:
  • Seasonal or perennial allergic rhinitis
  • Bronchial asthma
  • Contact dermatitis
  • Atopic dermatitis
  • Serum sickness
  • Drug hypersensitivity reactions

Usual Adult Dose for Atopic Dermatitis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Control of severe or incapacitating allergic conditions retractable to adequate trials of conventional treatment:
  • Seasonal or perennial allergic rhinitis
  • Bronchial asthma
  • Contact dermatitis
  • Atopic dermatitis
  • Serum sickness
  • Drug hypersensitivity reactions

Usual Adult Dose for Asthma

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Control of severe or incapacitating allergic conditions retractable to adequate trials of conventional treatment:
  • Seasonal or perennial allergic rhinitis
  • Bronchial asthma
  • Contact dermatitis
  • Atopic dermatitis
  • Serum sickness
  • Drug hypersensitivity reactions

Usual Adult Dose for Serum Sickness

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Control of severe or incapacitating allergic conditions retractable to adequate trials of conventional treatment:
  • Seasonal or perennial allergic rhinitis
  • Bronchial asthma
  • Contact dermatitis
  • Atopic dermatitis
  • Serum sickness
  • Drug hypersensitivity reactions

Usual Adult Dose for Ulcerative Colitis - Active

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: To tide patients over during critical periods of ulcerative colitis or regional enteritis

Usual Adult Dose for Tuberculous Meningitis

Initial dose: 25 to 300 mg per day

Comments:

  • Dose requirements are variable; individualize dose based on disease and patient response.

Uses: Tuberculosis meningitis with subarachnoid block or impending block (with appropriate concurrent tuberculosis chemotherapy); trichinosis with neurologic or myocardial event

Renal Dose Adjustments

Use with caution.

Liver Dose Adjustments

Data not available

Dose Adjustments

  • Doses less than 25 mg may suffice in less severe disease, while doses higher than 300 mg may be needed for severe disease.
  • Adjust initial dosage until a satisfactory response is seen.
  • If no satisfactory response occurs within a reasonable period, transfer the patient to a different therapy.
  • After a favorable initial response, determine the maintenance dose by decreasing the dose by small amounts to the lowest effective dose.
  • Observe patients carefully for signs that a dose adjustment may be needed, including changes from disease remission or exacerbation and the effects of stressors (e.g. surgery, infection, trauma).
  • Doses may need to be increased temporarily during times of stress.

Precautions

CONTRAINDICATIONS:

  • Systemic fungal infections
  • Hypersensitivity to this product

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • If therapy is to be discontinued after more than a few days of use, withdraw it gradually.

Patient advice:
  • Patients should avoid exposure to chickenpox and measles, and should seek medical advice promptly if exposed.

Frequently asked questions

  • What are the side effects of steroids?
  • What is the difference between hydrocortisone and cortisone?
  • How long do the effects of a cortisone injection shot last?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by